For most people on Medicare, the answer to whether Medicare covers Baqsimi is no: most Part D plans leave the nasal glucagon powder off their formularies, and the manufacturer’s savings card is legally unavailable to anyone with Medicare.1Drugs.com. Is Baqsimi Covered by Medicare2Drugs.com. How Much Does Baqsimi Cost3GoodRx. What Is Baqsimi though several assistance paths and a new Part D spending cap can bring that number down.
Check Your Specific Part D Plan
Part D plans set their own formularies, so coverage is plan-by-plan rather than a single Medicare rule. Pull your plan’s formulary document and search for Baqsimi by name. Even plans that list it may put it on a brand tier with coinsurance (a percentage of the list price rather than a flat copay), and some require prior authorization before paying.4PrescriberPoint. Baqsimi Prior Authorization Form Part D plans have been shifting more brand drugs from flat copays to coinsurance, which tends to raise out-of-pocket costs for products like Baqsimi.5USC Schaeffer Center. Medicare Part D Drug Costs IRA
What You’ll Pay Without Coverage
Without insurance, a single Baqsimi device runs about $305 to $310, and a two-pack averages around $685 at retail. Discount programs such as GoodRx can bring the two-pack down to roughly $563 to $566.3GoodRx. What Is Baqsimi No generic version is available. Note that cash prices paid with a discount card generally do not count toward your Part D out-of-pocket total, so if you have Medicare drug coverage, filling the prescription through your plan is usually the better long-term choice when you can.
Why the Baqsimi Savings Card Will Not Work
Baqsimi’s “Got Your BAQ” savings card can cut costs to as little as $25, but the fine print excludes anyone whose prescription is reimbursable by Medicare, Medicaid, TRICARE, the VA, or any other government program.6Baqsimi. Baqsimi Savings and Resources7HHS OIG. Manufacturer Safeguards May Not Prevent Copayment Coupon Use for Part D Drugs8The FDA Law Blog. Second Circuit Agrees That Copay Assistance Programs May Violate the Anti-Kickback Statute You cannot use the card even if a pharmacy offers to run it.
The Part D Annual Out-of-Pocket Cap
The Inflation Reduction Act created a hard annual cap on Part D out-of-pocket spending. It was set at $2,000 in 2025 and rises to $2,100 in 2026, covering deductibles, copays, and coinsurance combined.9KFF. Explaining the Prescription Drug Provisions in the Inflation Reduction Act Once you hit that threshold, covered drugs cost you nothing for the rest of the calendar year. For 2026, you can also choose to spread the $2,100 across the year in monthly installments of roughly $175 instead of paying it all at the start of the year.10MedicareResources.org. How Will the Inflation Reduction Act Affect Medicare Enrollees
The important limit: the cap only applies to drugs that are on your plan’s formulary. If your plan does not cover Baqsimi, what you pay for it does not count toward the cap and the cap does not reduce the price.
Help That Is Available to Medicare Enrollees
Extra Help (the Low-Income Subsidy)
Extra Help is the single largest cost reducer available for Part D drugs. For 2026, individuals with income up to $23,940 and resources below $18,090 may qualify; for couples the limits are $32,460 in income and $36,100 in resources.11Medicare.gov. Get Help With Drug Costs You qualify automatically if you have Medicaid, a Medicare Savings Program, or Supplemental Security Income.12Medicare Interactive. Extra Help Basics With Extra Help, you pay no Part D premium or deductible, brand-name copays are capped at $12.65 and generic copays at $5.10, and once total drug costs reach $2,100 your copays drop to zero. Baqsimi still has to be on your plan’s formulary for the subsidy to apply to it.
Independent Charitable Foundations
Unlike manufacturer copay cards, independent charities are generally allowed to help Medicare patients. The PAN Foundation and the Patient Advocate Foundation announced a merger in March 2026 and are launching a combined program called TotalAssist on July 1, 2026, running more than 140 disease-specific funds.13PAN Foundation. PAN Foundation The Patient Advocate Foundation’s Co-Pay Relief Program, developed with the American Diabetes Association, helps with diabetes-related medications, copays, deductibles, and premiums for people with Medicare, Medicaid, or military benefits whose household income is at or below 400% of the federal poverty level.14Copays.org. Diabetes Fund Whether a specific fund covers Baqsimi is not confirmed in public materials, so call 866-512-3861 or go to copays.org to check.15American Diabetes Association. Financial Assistance Available to People Living With Diabetes Through New Co-Pay Relief Fund RxAssist (rxassist.org) and NeedyMeds (needymeds.org) also maintain searchable databases of patient assistance programs.16ADCES. Cost Saving Resources for Non-Insulin Diabetes Medications
Calling Amphastar Directly
Baqsimi’s savings page directs government-insured patients to call Amphastar Pharmaceuticals at 1-800-423-4136 “to determine your eligibility for solutions based on your circumstances.”6Baqsimi. Baqsimi Savings and Resources The Lilly Cares Foundation historically provided free Lilly medications to qualifying patients, but Baqsimi’s status in that program after the divestiture to Amphastar is not confirmed.17Lilly Cares Foundation. Lilly Cares A 2025 professional resource listed no dedicated patient assistance program for Baqsimi,16ADCES. Cost Saving Resources for Non-Insulin Diabetes Medications so Amphastar’s line is the most reliable way to find out what is currently offered.
Alternatives Worth Discussing With Your Prescriber
Baqsimi is not the only emergency glucagon. The older injectable glucagon emergency kit is available as a generic, usually sits on a lower formulary tier, and costs less.18EmblemHealth. PPO City of New York Base Formulary Among brand-name competitors, Zegalogue (dasiglucagon, Novo Nordisk) is included in the Novo Nordisk Patient Assistance Program for uninsured and Medicare patients with household income at or below 400% of the federal poverty level. Gvoke (glucagon injection, Xeris) has a manufacturer program that explicitly excludes Medicare enrollees.16ADCES. Cost Saving Resources for Non-Insulin Diabetes Medications If Baqsimi is unaffordable, a prescriber may be able to switch you to a product your plan covers or whose assistance program accepts Medicare.